MENU
+Compare
CORT
Stock ticker: NASDAQ
AS OF
Oct 10, 04:59 PM (EDT)
Price
$73.95
Change
-$14.40 (-16.30%)
Capitalization
9.32B

CORT Corcept Therapeutics Forecast, Technical & Fundamental Analysis

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol... Show more

CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CORT with price predictions
Oct 09, 2025

Momentum Indicator for CORT turns positive, indicating new upward trend

CORT saw its Momentum Indicator move above the 0 level on September 17, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CORT just turned positive on September 08, 2025. Looking at past instances where CORT's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

CORT moved above its 50-day moving average on September 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CORT crossed bullishly above the 50-day moving average on September 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CORT advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 253 cases where CORT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CORT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CORT broke above its upper Bollinger Band on September 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CORT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.641) is normal, around the industry mean (23.645). P/E Ratio (78.893) is within average values for comparable stocks, (54.536). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.196). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (14.599) is also within normal values, averaging (350.442).

View a ticker or compare two or three
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CORT is expected to report earnings to fall 42.45% to 16 cents per share on October 29

Corcept Therapeutics CORT Stock Earnings Reports
Q3'25
Est.
$0.17
Q2'25
Beat
by $0.10
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.12
Q3'24
Beat
by $0.13
The last earnings report on July 31 showed earnings per share of 28 cents, beating the estimate of 18 cents. With 1.07M shares outstanding, the current market capitalization sits at 9.32B.
A.I. Advisor
published General Information

General Information

a maker of drugs for the treatment of severe psychiatric and neurological diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMUFX15.64N/A
N/A
Federated Hermes Muni and Stock Adv F
SUWIX39.10N/A
N/A
DWS Core Equity Inst
VSTSX318.01N/A
N/A
Vanguard Total Stock Mkt Idx Instl Sel
OFAVX27.70N/A
N/A
Olstein All Cap Value A
CRRVX9.56-0.05
-0.52%
Columbia Real Estate Equity Inst2

CORT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CORT has been loosely correlated with VTVT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORT
1D Price
Change %
CORT100%
-0.08%
VTVT - CORT
49%
Loosely correlated
+3.48%
TENX - CORT
41%
Loosely correlated
-0.77%
AGIO - CORT
41%
Loosely correlated
-0.40%
DNLI - CORT
40%
Loosely correlated
+3.32%
ARCT - CORT
37%
Loosely correlated
-7.17%
More